Omnihist II LA Interactions
There are 523 drugs known to interact with Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine), along with 25 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 38 are major, 467 are moderate, and 18 are minor.
- View all 523 medications that may interact with Omnihist II LA
- View Omnihist II LA alcohol/food interactions (2)
- View Omnihist II LA disease interactions (25)
Most frequently checked interactions
View interaction reports for Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine) and the medicines listed below.
- clonidine
- desmopressin
- Lexapro (escitalopram)
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- oxybutynin
- promethazine
- Risperdal (risperidone)
- Sea-Omega 30 (omega-3 polyunsaturated fatty acids)
- Singulair (montelukast)
- triamcinolone topical
- Veramyst (fluticasone nasal)
- Vyvanse (lisdexamfetamine)
- Xopenex HFA (levalbuterol)
Omnihist II LA alcohol/food interactions
There are 2 alcohol/food interactions with Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine).
Omnihist II LA disease interactions
There are 25 disease interactions with Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- cardiovascular disease
- cardiac disease
- tachycardia
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- BPH
- diabetes
- glaucoma
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
More about Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.